100TH GENERAL ASSEMBLY
State of Illinois
2017 and 2018
HB0679
 
Introduced , by Rep. Robyn Gabel
 
SYNOPSIS AS INTRODUCED:
 

 
410 ILCS 315/1.11 new

     Amends the Communicable Disease Prevention Act. Provides that the Department of Public Health shall develop an informational brochure relating to meningococcal disease that contains specified information. Provides that the Department shall make the brochure available on its website and shall notify every public institution of higher education in the State of the availability of the brochure. Provides that each public institution of higher education shall provide a copy of the brochure to all students and if the student is under 18 years of age, to the student's parent or guardian.
  


LRB100 06092 MJP 16124 b

 
 
A BILL FOR
 

  
HB0679LRB100 06092 MJP 16124 b


  
1    AN ACT concerning health.
  
 
2    Be it enacted by the People of the State of Illinois,
 
3represented in the General Assembly:
  
 
 
4    Section 5. The Communicable Disease Prevention Act is 
5amended by adding Section 1.11 as follows:
 
6    (410 ILCS 315/1.11 new)
7    Sec. 1.11. Meningococcal disease brochure. The Department 
8of Public Health shall develop an informational brochure 
9relating to meningococcal disease that states that 
10immunizations against meningococcal disease are available. The 
11Department of Public Health shall make the brochure available 
12on its website and shall notify every public institution of 
13higher education in the State of the availability of the 
14brochure. Each public institution of higher education shall 
15provide a copy of the brochure to all students and if the 
16student is under 18 years of age, to the student's parent or 
17guardian. Such information in the brochure shall include:
18        (1) the risk factors for and symptoms of meningococcal 
19    disease, how it may be diagnosed, and its possible 
20    consequences if untreated;
21        (2) how meningococcal disease is transmitted;
22        (3) the latest scientific information on meningococcal 
23    disease immunization and its effectiveness, including 
 
 
HB0679- 2 -LRB100 06092 MJP 16124 b

1    information on all meningococcal vaccines receiving a 
2    Category A or B recommendation from the Centers for Disease 
3    Control and Prevention's Advisory Committee on 
4    Immunization Practices;
5        (4) a statement that any questions or concerns 
6    regarding immunization against meningococcal disease may 
7    be answered by contacting the individual's health care 
8    provider; and
9        (5) a recommendation that the current student or 
10    entering student receive meningococcal vaccines in 
11    accordance with current guideline from the Centers for 
12    Disease Control and Prevention's Advisory Committee on 
13    Immunization Practices.